CellWell record HH-561064
Early and late CTCAE and patient-reported outcomes following breast radiotherapy in the REQUITE cohort
Tina Bockstiegel; Adam Webb; Miguel E. Aguado-Barrera; Ester Aguado-Flor; Manuel Altabas; Marianne Aznar; David Azria; Erik Briers; Renée Bultijnck; Jenny Chang-Claude; Alessandro Cicchetti; Maria Carmen De Santis
Clinical and Translational Radiation Oncology · 2027
In plain language
In 2,057 women with breast cancer in the REQUITE cohort, grade 2 or higher acute pain and skin ulceration were more frequent after normofractionation than hypofractionation radiotherapy.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-561064
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.